Journal
EXPERT REVIEW OF ANTICANCER THERAPY
Volume 17, Issue 8, Pages 657-659Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14737140.2017.1351355
Keywords
Glioblastoma; value; costs; cost-effectiveness; glioma